Prepare for the Clinical Chemistry and Pathologic of Biochemistry Exam with comprehensive questions, detailed explanations, and effective study strategies. Ace your test with confidence!

Multiple Choice

What factors can cause discordant HbA1c results in diverse populations, and what alternatives exist?

The main idea is that HbA1c can be discordant with true average glucose when factors affecting hemoglobin or red cell lifespan differ, and that there are alternative ways to assess glycemic control in those scenarios. HbA1c depends on how long red blood cells live and how readily glucose attaches to hemoglobin. In diverse populations, hemoglobin variants (like HbS, HbC, HbD, or elevated fetal Hb) and conditions that shorten or prolong RBC lifespan (anemia, iron deficiency, recent transfusions, pregnancy, kidney disease) can alter HbA1c independently of actual glucose levels. Because of this, HbA1c may misrepresent glycemic control for certain individuals. Alternatives exist to capture glycemia when HbA1c is unreliable. Fructosamine and glycated albumin reflect glycation on serum proteins over a shorter period (roughly 2–3 weeks) and are not affected by RBC turnover or most Hb variants. Other HbA1c assay methods can be chosen or validated to minimize interference from common variants. In addition, glucose-based measures such as fasting plasma glucose, the oral glucose tolerance test, or continuous glucose monitoring can provide useful information about glycemic status when HbA1c is not trustworthy. So the best description among these ideas is the one that cites hemoglobin variants and RBC turnover as factors causing discordance and lists fructosamine, glycated albumin, or different HbA1c assay methods as practical alternatives. The other statements either attribute discordance to a single factor, claim there are no alternatives, or assert HbA1c is always accurate, which isn’t correct.

The main idea is that HbA1c can be discordant with true average glucose when factors affecting hemoglobin or red cell lifespan differ, and that there are alternative ways to assess glycemic control in those scenarios. HbA1c depends on how long red blood cells live and how readily glucose attaches to hemoglobin. In diverse populations, hemoglobin variants (like HbS, HbC, HbD, or elevated fetal Hb) and conditions that shorten or prolong RBC lifespan (anemia, iron deficiency, recent transfusions, pregnancy, kidney disease) can alter HbA1c independently of actual glucose levels. Because of this, HbA1c may misrepresent glycemic control for certain individuals.

Alternatives exist to capture glycemia when HbA1c is unreliable. Fructosamine and glycated albumin reflect glycation on serum proteins over a shorter period (roughly 2–3 weeks) and are not affected by RBC turnover or most Hb variants. Other HbA1c assay methods can be chosen or validated to minimize interference from common variants. In addition, glucose-based measures such as fasting plasma glucose, the oral glucose tolerance test, or continuous glucose monitoring can provide useful information about glycemic status when HbA1c is not trustworthy.

So the best description among these ideas is the one that cites hemoglobin variants and RBC turnover as factors causing discordance and lists fructosamine, glycated albumin, or different HbA1c assay methods as practical alternatives. The other statements either attribute discordance to a single factor, claim there are no alternatives, or assert HbA1c is always accurate, which isn’t correct.